Sign in

Publications

Search in 13054 publications:

Reset RSS
Time frame
13054 Publication(s)
Aug 23, 2019
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Hoyle A, Aebersold D, Jones R, Matheson D, Millman R, Mason M, Ritchie A, Russell M, Douis H, Parmar M, Sydes M, Clarke N, Gillessen Sommer S, Ingleby F, Ali A, James N, Cook A, Parker C, de Bono J, Attard G, Chowdhury S, Cross W, Dearnaley D, Brawley C, Gilson C, STAMPEDE Investigators. Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. Eur Urol 2019; 76:719-728.
Aug 23, 2019
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Aug 23, 2019

Eur Urol 2019; 76:719-728

Hoyle Alex P, Aebersold Daniel M, Jones Rob J, Matheson David, Millman Robin, Mason Malcolm D, Ritchie Alastair W S, Russell Martin, Douis Hassan, Parmar Mahesh K B, Sydes Matthew R, Clarke Noel W, Gillessen Sommer Silke, Ingleby Fiona, Ali Adnan, James Nicholas D, Cook Adrian, Parker Christopher C, de Bono Johann S, Attard Gerhardt, Chowdhury Simon, Cross William R, Dearnaley David P, Brawley Christopher D, Gilson Clare, STAMPEDE Investigators

more
Aug 23, 2019
Sexualität bei Krebserkrankungen
Siercks I (2019). Sexualität bei Krebserkrankungen. Presented at: Nachdiplomstudium Onkologiepflege 2019, St. Gallen
Aug 23, 2019
Sexualität bei Krebserkrankungen
Aug 23, 2019

Nachdiplomstudium Onkologiepflege 2019

Siercks Ikbale

more
Aug 23, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Hasan Ali O, Sadik C, Zillikens D, Schmidt E, Jochum W, Mani B, Cozzio A, Braun A, Emtenani S, Hammers C, Abdou M, Diem S, Fässler M, Berner F, Ring S, Bomze D, Flatz L. BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. J Am Acad Dermatol 2019; 82:854-861.
Aug 23, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Aug 23, 2019

J Am Acad Dermatol 2019; 82:854-861

Hasan Ali Omar, Sadik Christian D, Zillikens Detlef, Schmidt Enno, Jochum Wolfram, Mani Bernhard, Cozzio Antonio, Braun Anne, Emtenani Shirin, Hammers Christoph, Abdou Marie-Therese, Diem Stefan, Fässler Mirjam, Berner Fiamma, Ring Sandra S, Bomze David, Flatz Lukas

more
Aug 22, 2019
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
Kratochwil C, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester H, Bodei L, Fanti S, Haberkorn U, Kopka K, Konijnenberg M, Kabasakal L, Fendler W, Eiber M, Baum R, Bozkurt M, Czernin J, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Herrmann K. EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2019; 46:2536-2544.
Aug 22, 2019
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
Aug 22, 2019

Eur J Nucl Med Mol Imaging 2019; 46:2536-2544

Kratochwil Clemens, Lassmann Michael, Mottaghy Felix M, Oyen Wim, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Wester Hans-Jürgen, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Kopka Klaus, Konijnenberg Mark, Kabasakal Levant, Fendler Wolfgang Peter, Eiber Matthias, Baum Richard, Bozkurt Murat Fani, Czernin Johannes, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Herrmann Ken

more
Aug 22, 2019
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
Bomze D, Hasan Ali O, Bate A, Flatz L. Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden. JAMA Oncol 2019
Aug 22, 2019
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
Aug 22, 2019

JAMA Oncol 2019

Bomze David, Hasan Ali Omar, Bate Andrew, Flatz Lukas

more
Aug 21, 2019
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma
Hartmann S, Hansmann M, Engert A, Rosenwald A, Möller P, Klapper W, Stein H, Quintanilla-Martinez L, Fend F, Cogliatti S, Ott G, Feller A, Bernd H, Mottok A, Plütschow A, Eichenauer D. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol 2019; 94:1208-1213.
Aug 21, 2019
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma
Aug 21, 2019

Am J Hematol 2019; 94:1208-1213

Hartmann Sylvia, Hansmann Martin-Leo, Engert Andreas, Rosenwald Andreas, Möller Peter, Klapper Wolfram, Stein Harald, Quintanilla-Martinez Leticia, Fend Falko, Cogliatti Sergio B., Ott German, Feller Alfred C, Bernd Heinz-Wolfram, Mottok Anja, Plütschow Annette, Eichenauer Dennis A

more
Aug 21, 2019
Building a Global Alliance in Vascular Surgery
White J, Conte M, Bradbury A, Kolh P, Dick F, Fitridge R, Mills J, Ricco J, Suresh K. Building a Global Alliance in Vascular Surgery. Eur J Vasc Endovasc Surg 2019; 58:318-319.
Aug 21, 2019
Building a Global Alliance in Vascular Surgery
Aug 21, 2019

Eur J Vasc Endovasc Surg 2019; 58:318-319

White John, Conte Michael, Bradbury Andrew, Kolh Philippe, Dick Florian, Fitridge Robert, Mills Joseph, Ricco Jean-Baptiste, Suresh Kal

more
Aug 21, 2019
Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair
Guber J, Bentivoglio M, Scholl H, Sturm V, Valmaggia C. Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair. Clin Ophthalmol. 2019:1587-1591.
Aug 21, 2019
Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair
Aug 21, 2019

Clin Ophthalmol. 2019:1587-1591

Guber Josef, Bentivoglio Maico, Scholl Hendrik P. N., Sturm Veit, Valmaggia Christophe

more
Aug 19, 2019
New clinical guidelines on the spinal stabilisation of adult trauma patients - consensus and evidence based.
Maschmann C, Jeppesen E, Rubin M, Barfod C. New clinical guidelines on the spinal stabilisation of adult trauma patients - consensus and evidence based. Scand J Trauma Resusc Emerg Med 2019; 27:77.
Aug 19, 2019
New clinical guidelines on the spinal stabilisation of adult trauma patients - consensus and evidence based.
Aug 19, 2019

Scand J Trauma Resusc Emerg Med 2019; 27:77

Maschmann Christian, Jeppesen Elisabeth, Rubin Monika Afzali, Barfod Charlotte

more
Aug 19, 2019
Den akutte patient
Maschmann C. Den akutte patient - Akutte smerter, vurdering og behandling. In: Den akutte patient. 4Copenhagen: Gyldendal, 2019. ISBN 9788762818941. pp. 503-522.
Aug 19, 2019
Den akutte patient
Aug 19, 2019

Gyldendal, ISBN 9788762818941

Maschmann Christian

more
Aug 19, 2019
Den akutte patient
Maschmann C. Den akutte patient - Prehospital behandling og transport af patienter. In: Den akutte patient. 4Copenhagen: Gyldendal, 2019. ISBN 9788762818941. pp. 537-547.
Aug 19, 2019
Den akutte patient
Aug 19, 2019

Gyldendal, ISBN 9788762818941

Maschmann Christian

more
Aug 18, 2019
Contralateral MRI scan can be used reliably for three-dimensional meniscus sizing - Retrospective analysis of 160 healthy menisci
Beeler S, Vlachopoulos L, Jud L, Sutter R, Fürnstahl P, Fucentese S. Contralateral MRI scan can be used reliably for three-dimensional meniscus sizing - Retrospective analysis of 160 healthy menisci. Knee 2019; 26:954-961.
Aug 18, 2019
Contralateral MRI scan can be used reliably for three-dimensional meniscus sizing - Retrospective analysis of 160 healthy menisci
Aug 18, 2019

Knee 2019; 26:954-961

Beeler Silvan, Vlachopoulos Lazaros, Jud Lukas, Sutter Reto, Fürnstahl Philipp, Fucentese Sandro F

more
Aug 16, 2019
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer
Buechler S, Badve S, Leyland-Jones B, Viale G, Kammler R, Thürlimann B, Willis S, Gökmen-Polar Y, Gray K, Regan M. Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer. JNCI Cancer Spectr 2019; 3:pkz051.
Aug 16, 2019
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer
Aug 16, 2019

JNCI Cancer Spectr 2019; 3:pkz051

Buechler Steven A, Badve Sunil S, Leyland-Jones Brian, Viale Giuseppe, Kammler Rosita, Thürlimann Beat, Willis Scooter, Gökmen-Polar Yesim, Gray Kathryn P, Regan Meredith M

more
Aug 16, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Bochem J, Weide B, Pawelec G, Garbe C, Meier F, Terheyden P, Uslu U, Wagner N, Eigentler T, Soffel D, Spreuer J, Amaral T, Zelba H, Wistuba-Hamprecht K. Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade. PloS one 2019; 14:e0221301.
Aug 16, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Aug 16, 2019

PloS one 2019; 14:e0221301

Bochem Jonas, Weide Benjamin, Pawelec Graham, Garbe Claus, Meier Friedegund, Terheyden Patrick, Uslu Ugur, Wagner Nikolaus, Eigentler Thomas, Soffel Daniel, Spreuer Janine, Amaral Teresa, Zelba Henning, Wistuba-Hamprecht Kilian

more
Aug 13, 2019
Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses
Rieckmann M, van der Laan A, Piek J, Koch C, Wester H, Lapa C, Bauer W, Ludewig B, Friedman N, Frantz S, Hofmann U, Krijnen P, Niessen H, Delgobo M, Gaal C, Büchner L, Steinau P, Reshef D, Gil Cruz C, Ter Horst E, Kircher M, Reiter T, Heinze K, Ramos G. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest 2019; 130
Aug 13, 2019
Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses
Aug 13, 2019

J Clin Invest 2019; 130

Rieckmann Max, van der Laan Anja M, Piek Jan J, Koch Charlotte, Wester Hans-Jürgen, Lapa Constantin, Bauer Wolfgang R, Ludewig Burkhard, Friedman Nir, Frantz Stefan, Hofmann Ulrich, Krijnen Paul Aj, Niessen Hans Wm, Delgobo Murilo, Gaal Chiara, Büchner Lotte, Steinau Philipp, Reshef Dan, Gil Cruz Cristina, Ter Horst Ellis N, Kircher Malte, Reiter Theresa, Heinze Katrin G, Ramos Gustavo Campos

more
Aug 13, 2019
Antikonzeption nach tiefer Venethrombose
Kühn-Lichtenberg A (2019). Antikonzeption nach tiefer Venethrombose. Presented at: Alice Kühn-Lichtenberg, Ärztefortbildung Frauenklinik KSSG
Aug 13, 2019
Antikonzeption nach tiefer Venethrombose
Aug 13, 2019

Alice Kühn-Lichtenberg

Kühn-Lichtenberg Alice

more
Aug 11, 2019
Outcome after out-of-hospital ventricular fibrillation or pulseless ventricular tachycardia: comparison of before and after the implementation of the 2010 Guidelines in a single centre
von Hösslin T, Imboden P, Kaufmann C, Schnider T, Filipovic M. Outcome after out-of-hospital ventricular fibrillation or pulseless ventricular tachycardia: comparison of before and after the implementation of the 2010 Guidelines in a single centre. Swiss Med Wkly 2019; 149:w20101.
Aug 11, 2019
Outcome after out-of-hospital ventricular fibrillation or pulseless ventricular tachycardia: comparison of before and after the implementation of the 2010 Guidelines in a single centre
Aug 11, 2019

Swiss Med Wkly 2019; 149:w20101

von Hösslin Thomas, Imboden Paul, Kaufmann Corina, Schnider Thomas, Filipovic Miodrag

more
Aug 9, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Schuler M, Gajate P, Cathomas R, Rajagopalan P, Grevel J, Bender S, Boix O, Nogai H, Ocker M, Ellinghaus P, Schostak M, Park S, Cho B, Sayehli C, Navarro A, Soo R, Richly H, Cassier P, Tai D, Penel N, Nogova L, Jörger M. Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study. Lancet Oncol 2019
Aug 9, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Aug 9, 2019

Lancet Oncol 2019

Schuler Martin, Gajate Pablo, Cathomas Richard, Rajagopalan Prabhu, Grevel Joachim, Bender Sebastian, Boix Oliver, Nogai Hendrik, Ocker Matthias, Ellinghaus Peter, Schostak Martin, Park Se Hoon, Cho Byoung Chul, Sayehli Cyrus Michael, Navarro Alejandro, Soo Ross A, Richly Heike, Cassier Philippe Alexandre, Tai David, Penel Nicolas, Nogova Lucia, Jörger Markus

more
Aug 9, 2019
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Robertz J, Andres M, Mansouri Taleghani B, Koneth I, Binet F, Kremer Hovinga J. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Am J Hematol 2019; 94:E259-E261.
Aug 9, 2019
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Aug 9, 2019

Am J Hematol 2019; 94:E259-E261

Robertz Judith, Andres Martin, Mansouri Taleghani Behrouz, Koneth Irene, Binet Françoise-Isabelle, Kremer Hovinga Johanna A

more
Aug 9, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Silzle T, Blum S, Schuler E, Kaivers J, Rudelius M, Hildebrandt B, Gattermann N, Haas R, Germing U. Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients. Blood Cancer J 2019; 9:63.
Aug 9, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Aug 9, 2019

Blood Cancer J 2019; 9:63

Silzle Tobias, Blum Sabine, Schuler Esther, Kaivers Jennifer, Rudelius Martina, Hildebrandt Barbara, Gattermann Norbert, Haas Rainer, Germing Ulrich

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy